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Abstract
The hepatitis C virus (HCV) core protein is considered to influence multiple cellular processes. We developed a human hepatoblastoma
HepG2-derived inducible cell line, Hep191, which allows tightly regulated expression of the core protein at relatively low but physiological
levels under control of the ecdysone-regulated promoter. By transcriptional profiling, we identified differentially expressed genes, some of
which are involved in cell growth or apoptosis such as inhibitor of caspase-activated DNase (ICAD), defender against cell death 1, tumor
necrosis factor (TNF) receptor 1, and cytochrome c oxidase subunit VIII. Furthermore, we found that core protein expression increases a
steady-state level of ICAD protein, possibly through enhancing its promoter activity, and inhibits caspase-3 activity induced by anti-Fas
antibody. Since Fas- or TNF-mediated DNA fragmentation is suppressed in the core-induced Hep191 cells, these findings suggest that
expression of HCV core at physiological levels confers blocking activity of caspase-activated DNase and consequently inhibiting apoptotic
cell death.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
A main characteristic feature of hepatitis C virus (HCV)
infection is its persistent nature, which often leads to
chronic hepatitis and liver cirrhosis. HCV infection is also
strongly associated with the development of hepatocellular
carcinoma (HCC) (Choo et al., 1989; Kuo et al., 1989; Saito
et al., 1990). Another characteristic is its highly specific host
range for replication. To understand the exact mechanism of
pathogenesis and persistence of HCV infection, it is impor-
tant to elucidate virus–cell interaction, particularly in he-
patic cells. We have been interested in the role of HCV core
protein, which constitutes not only viral nucleocapsids but
has multifunctions for pathogenesis or establishment of per-
sistent infection of HCV (Lai and Ware, 1999; Thomson
and Liang, 2000; Suzuki et al., 1999).
Apoptosis is definitely one of the key factors associated
with liver injury and chronicity of HCV infection (Hayashi
and Mita, 1997; Lau et al., 1998; Patel et al., 1998). How-
ever, its molecular mechanism is not clear yet. Apoptosis
mediated by Fas or tumor necrosis factor (TNF) is a major
pathway involved in a wide range of liver diseases. When
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Fas is constitutively expressed in hepatocytes and when
agonistic anti-Fas antibodies are injected, the animals de-
velop fatal fulminant hepatitis (Ogasawara et al., 1993;
Lacronique et al., 1996). On the other hand, several HCV
proteins have been reported to modulate apoptosis induced
by diverse stimuli in different experimental systems (Ray et
al., 1996, 1998; Fujita et al., 1996; Ruggieri et al., 1997;
Zhu et al., 1998, 2001; Marusawa et al., 1999; Dumoulin et
al., 1999; Gale et al., 1999; Hahn et al., 2000; Tai et al.,
2000; Honda et al., 2000; Otsuka et al., 2002). However, the
data shown to date, particularly with regards to the effects of
the core protein, are not consistent. Several studies showed
that the viral protein sensitizes apoptosis mediated by Fas,
TNF-, or other signaling pathways, whereas other studies
showed inhibition of such apoptosis. Difficulty in unravel-
ing of functions of HCV proteins on pathogenesis might be
due to, at least in part, the fact that many previous investi-
gations were based on transient or stable expression systems
using unrelevantly high expression systems. In these sys-
tems, only certain populations of cells expressing viral pro-
teins at high levels were selected. Such settings may be
different from those of chronic infection, where only low
production of viral proteins is observed.
In the current study, we overcame this problem through
the use of the ecdysone-based inducible system, in which
expression of HCV core protein can be induced at physio-
logical levels in the same cellular background. The combi-
nation of transcriptional profiling with functional studies
demonstrated the alteration of expression of several cellular
genes including those related to apoptosis. It is of interest to
note that expression of the core protein increased a steady-
state protein level of inhibitor of caspase-activated DNase
(ICAD), possibly through enhancing its promoter activity,
and inhibited caspase-3 activity induced by anti-Fas anti-
body. In addition, induced expression of HCV core protein
inhibited Fas- and TNF-mediated DNA fragmentation.
These findings suggest that up-regulation of ICAD and
inhibition of caspase-3 activity by the core protein collabo-
ratively play roles in inhibiting apoptotic cell death through
blocking activity of caspase-activated DNase (CAD).
Results
Establishment of a cell line allowing the tightly regulated
expression of HCV core protein
The ecdysone-inducible system was used to generate
tightly regulated cell lines expressing HCV core protein.
This system is based on the binding of the steroid hormone
ecdysone analog such as ponasterone A (PNA) to a het-
erodimeric receptor comprising a modified ecdysone recep-
tor (VgEcR) and retinoid X receptor (RXR). The binding
subsequently activates the ecdysone-responsive promoter to
express the target genes (No et al., 1996). After keeping the
transfected culture for 3 weeks in the presence of Hygro-
mycin and Zeocin, 27 Zeocin-Hygromycin-resistant clones
were isolated. They were then screened for regulated HCV
core expression by sensitive fluorescence enzyme immuno-
assay (FEIA) and Western blot analysis. Being induced by
treatment with PNA (0.3–30 M) for 36 h, three of these
clones (designated as Hep191) showed tightly regulated
expression of the core protein. Western blot analysis of
Hep191, clone 3 showed induction of 21-kDa HCV core
protein in the presence of 30 M PNA. It was not detected
in the absence of PNA (Fig. 1A). FEIA analysis revealed
that HCV core protein was observed as early as 3 h after
addition of PNA and increased consistently up to 24 h.
Continuous treatment with PNA showed that intracellular
level of the core protein achieved after 24-h treatment was
maintained during the whole culture period. Induced ex-
pression of the core protein was confirmed by indirect
immunofluorescence staining (Fig. 1B). HCV core protein
induced by treatment with 30 M PNA for 48 h was
localized exclusively within the cytoplasm. It seems that the
core protein was essentially expressed uniformly in the
induced Hep191 cells. No immunoreactivity was observed
when the cells were cultured in the absence of PNA (data
not shown).
We then examined “turning off” the regulation. Tran-
scription intermediates of HCV core gene were monitored
by reverse transcription-polymerase chain reaction (RT-
PCR) in the cells in which the PNA medium was replaced
by the vehicle-containing medium (Fig. 1C). No HCV
cDNA transcript was detectable after 24 h of PNA removal.
Correspondingly, HCV core protein level decreased and it
was not observed after 24 h of withdrawal by Western
blotting (data not shown). Further quantitative analysis by
FEIA indicated that PNA’s HCV core protein induction is in
a concentration-dependent manner with the range of 0.3–30
M of PNA for 36 h (Fig. 1D). No detectable level of HCV
core protein was observed in the cells not treated with PNA,
indicating negligible background of expression in the unin-
duced states. Notably, this core protein level in Hep191 is
comparable to those in the livers of hepatitis C patients
(6–1000 pg/mg total protein) and the transgenic mice de-
veloping hepatic steatosis and HCC (13–804 pg/mg total
protein)(Koike et al., 2002; Tsutsumi et al., 2003).
Previous studies examining functional properties of
HCV proteins have been performed mainly in cells over-
producing the viral proteins. Moreover, many of them were
nonhuman liver cells or human nonliver cells. Our human
liver cell derived Hep191 cells allow the tightly regulated
expression of core protein at a physiological level. This will
provide a unique system to investigate possible roles of core
protein in viral pathogenesis. In most of the following ex-
periments, Hep191, clone 3 was used and core protein
expression was induced by adding 10 M PNA. Under this
condition, the core protein level in the cells was approxi-
mately 500 to 1000 pg/mg total protein, which was little
detected by Western blotting. We obtained similar results
with the other two clones 21 and 37. These three clones
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have been maintained in culture for over 20 months and
more than 90 passages without loss of tightly regulated gene
expression.
Cell growth properties
To test the effects of induced expression of HCV core
protein on cell growth, Hep191 cells were cultured in daily
changed medium with or without PNA. The number of
viable cells was determined by counting daily for 10 days.
As shown in Fig. 2A, no differences were noted between
growth curves of Hep191 cultured in the medium with 10%
fetal bovine serum (FBS) in the presence and absence of
PNA. Furthermore, the same saturation density was reached
under both conditions. The result demonstrates that HCV
core protein expressed in Hep191 cells has no influence on
growth capacity, which is consistent with that in previous
studies using human hepatoma Huh-7 cells (Li et al., 2002)
and human osteosarcoma U-2OS cells (Moradpour et al.,
1996) with tetracycline-inducible systems. Analogous re-
sults were found in slower growing Hep191 cells cultured in
1% FBS-containing medium (Fig. 2B), suggesting that core
expression does not confer serum independence to the cells.
We also observed that the inducing agent, PNA, exerted no
pleiotropic effects, confirming the advantage of using ec-
dysteroids, which are known not to affect physiology of
mammalian cells.
Changes in gene expression in the core-induced Hep191 cells
We then compared the gene expression patterns in
Hep191 cells in the presence and absence of 10 M PNA.
Fig. 1. Inducible expression of HCV core protein in Hep191 cells, clone 3. (A) Hep191 cells cultured in the presence () and absence () of 30 M
ponasterone A (PNA) for 36 h were analyzed by Western blotting with anticore monoclonal antibody. Arrow shows the core protein. The sizes in kDa of
molecular mass markers are indicated on the left. (B) Indirect immunofluorescence staining of Hep191 cells after 48-h treatment with 30 M PNA by
monoclonal anticore antibody. (C) Tight control of the core gene expression was determined by RT-PCR. Total RNAs were isolated from Hep191 cells before
PNA treatment (lane 1), after 24-h treatment (lane 2). Subsequently, the treated cells were washed, followed by another culture in the vehicle-containing
medium for 24 h (lane 3) or 48 h (lane 4). RT-PCR was performed using primers specific for genes of the core (top) and glyceraldehyde-3-phosphatase
dehydrogenase (GAPDH) (bottom). Molecular size marker is shown at the left sides in both panels (M). (D) Core protein levels in Hep191 cells cultured
with various concentrations of PNA for 36 h was quantified by FEIA. Data shown represent the mean values with standard deviation (S.D.) of triplicate
experiments.
Fig. 2. Cell growth analysis. Hep191 cells were grown in the medium with
10% (A) and 1% (B) FBS in either the presence (closed circle) or the
absence (open circle) of 10 M PNA and were counted every other day as
described under Materials and methods. Results show the mean cell num-
bers in each dish obtained from triplicate experiments.
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A cDNA microarray consisting of 2304 human genes was
used. cDNA labeling reactions were carried out in duplicate
where the fluorescent dyes, Cy3 and Cy5, were switched
during the synthesis, followed by hybridizing each probe
pair to a separate microarray. A list of the genes demon-
strating greater than two-fold change in average of two
experiments is provided in Table 1. We observed 12 genes
up-regulated and 8 genes down-regulated upon induction of
the core protein. Most of the genes differentially expressed
were regulators of either transcription, RNA/protein metab-
olism, apoptosis, or signaling molecules. Among these, four
genes which are involved in apoptosis regulation are note-
worthy: the expression of (i) ICAD and (ii) defender against
cell death 1 (DAD1) was increased, whereas the expression
of (iii) TNF receptor 1 (TNFR1) and (iv) cytochrome c
oxidase subunit VIII was decreased in the core-induced
Hep191 cells.
To validate the differential expression of these genes, we
performed semiquantitative RT-PCR analysis. For each as-
say, the reaction conditions and cycle numbers of PCR were
individually optimized and adjusted so that the reaction fell
within the linear range of product amplification. Glyceral-
dehyde-3-phosphatase dehydrogenase (GAPDH), whose
expression was not altered, was used as a control for load-
ing. Our RT-PCR qualitatively agreed with the expression
patterns generated by microarray data (Fig. 3A). PNA itself
had no effect, or little if any, on these gene expressions in
control HepRXR cells, which are not expressing the core
protein. In addition to analyzing clone 3 of Hep191, semi-
quantitative RT-PCR was also performed with ICAD and
GAPDH genes of clone 37 (Fig. 3B). In good agreement
with that observed with clone 3, expression of ICAD gene
was up-regulated after induced expression of the core pro-
tein in clone 37.
Expression of the core protein resulted in activation of
the ICAD promoter
We next focused on the impact of the core protein on
ICAD expression. ICAD is a 45-kDa inhibitor of CAD,
caspase-activated DNase, of 40-kDa (Liu et al., 1997; Enari
et al., 1998). ICAD exists as a complex with CAD in
Table 1
Genes up- or down-regulated by expression of HCV core protein in Hep191 cells
Accession no. Gene name Category Fold change
AK091194 Probable trans-1,2-dihydrobenzene-1,2-dioldehydrogenase Metabolism 2.3
Y12653 Diubiquitin Immune response 2.2
M90657 Tumor-associated antigen L6 Tumor associated 2.2
Y12065 Nucleolar protein hNop56 RNA/protein metabolism 2.1
S54005 Thymosin beta-10 Cell motility 2.1
X74981 Keratin 8 Cell structure 2.1
M29064/M29065 Heterogeneous nuclear ribonucleoprotein A2/B1 RNA/protein metabolism 2.1
U91985 Inhibitor of caspase-activated DNase (ICAD) Apoptosis 2.1
AH000826 Dihydrodiol dehydrogenase Metabolism 2.1
D15057 Deffender against cell death 1, DAD1 Apoptosis 2.0
L22009 hnRNP H RNA/protein metabolism 2.0
P05215 Tubulin alpha-4 chain Cell structure 2.0
AF517226 Insulin-like growth factor 2 (somatomedin A) Signaling 0.3
X54989 Evi-1 Signaling 0.4
M55422 Krueppel-related zinc finger protein, H-plk Transcription 0.4
J04823 Cytochrome C oxidase subunit VIII-liver/heart precursor Apoptosis 0.4
P09565 Putative insulin-like growth factor II associated protein Signaling 0.4
M75866 TNF receptor 1 Apoptosis 0.4
BC037225 AP-2 beta (activating enhancer-binding protein 2 beta) Transcription 0.5
U10439 Double-stranded RNA adenosine deaminase RNA/protein metabolism 0.5
Note. Genes with two-fold or more increase (top) or decrease (bottom) in average of two experiments are indicated.
Fig. 3. Semiquantitative RT-PCR analysis of differentially expressed genes
which are related to apoptosis. Total RNAs were extracted from Hep191
clone 3 (A) or clone 37 (B) and HepRXR cells cultured either with () or
without () 10 M PNA, followed by semiquantitative RT-PCR analysis.
GAPDH was amplified in parallel as a control.
27R. Sacco et al. / Virology 317 (2003) 24–35
proliferating cells. Upon apoptotic stimuli, caspases, partic-
ularly caspase-3, proteolytically process ICAD to release
CAD from the complex, allowing CAD to catalyze the
fragmentation of chromosomal DNA. As shown in Fig. 4A,
we found a significant increase in ICAD protein in Hep191
cells treated with 10 M PNA for 48 h by Western blotting,
whereas no change was observed in the control cells with
the same treatment.
To address the molecular mechanism of up-regulation of
ICAD expression by core protein, we examined whether the
core expression is linked to ICAD promoter activity. ICAD
promoter/luciferase reporter constructs used in this study
are generous gifts from Dr. S. Nagata (Kawane et al., 1999).
However, HepG2-based Hep191 cells have low transfection
efficiency, and these cells were not suitable for cotransfec-
tion experiments of control and experimental reporter vec-
tors. We therefore adopted the 293T transient transfection
system, in which transfection efficiency of each plasmid
exhibits constantly about 80%. As shown in Fig. 4B, lucif-
erase activity expressed from ICAD reporter construct,
which includes the 110-bp 5 flanking region of the ICAD
gene (pIPT-2), increased twofold following expression of
the core protein. On the other hand, the 39-bp deletion at 5
region of the promoter (pIPT-3) resulted in a marked de-
crease with the core expression. The 39-bp region thus plays
a role in regulating ICAD promoter activity by HCV core
protein. Further 24-bp deletion (pIPT-4) caused threefold
reduction of the activity in cells in both the presence and the
absence of the core protein. The ICAD gene used in this
reporter assay was murine in origin, but its 110-bp promoter
region has 75% sequence identity to that in human ICAD
gene. Furthermore, the putative binding sites for transcrip-
tion factors, such as USF1 and GATA-1 in the 39-bp region,
are well conserved between murine and human ICAD
genes. Thus, these data indicate that stimulation of ICAD
promoter activity by the core protein results in an elevated
level of ICAD protein in the core-expressing cells.
Effects of HCV core protein expression on Fas- and TNF-
-mediated DNA fragmentation in Hep191 cells
The above observation showing changes in expression of
several apoptosis-related genes prompted us to study the
role of HCV core protein in Fas- or TNF--mediated apo-
ptosis pathway. Hep191 cells with or without core induction
were treated with anti-Fas antibody for 14 h. DNA ladders
due to activation of nuclear endonucleases were then mea-
sured by quantitating cytoplasmic mono- and oligonucleo-
somes. As indicated in Fig. 5A, Hep191 cells treated with
10 M PNA showed decreased sensitivity against anti-Fas-
induced DNA fragmentation. DNA-associated mono- and
oligonucleosomes released into cytoplasm were reduced to
28% in the core-expressing Hep191 cells. To exclude the
direct effects of PNA in apoptotic response, we examined
the Fas-induced DNA fragmentation also in the control
HepRXR cells. No difference in apoptotic response was
observed in HepRXR cells in either the presence or the
absence of PNA (Fig. 5A). Prolonged induction of the core
protein expression for 15 or 30 days with 10 M PNA also
inhibited the Fas- and TNF--mediated apoptosis (Fig. 5B).
We further investigated the relation of induced HCV
core protein and Fas-mediated apoptotic response. As
shown by the terminal deoxynucleotidyltransferase-medi-
ated dUTP nick end-labeling (TUNEL) technique in Fig. 6,
anti-Fas-treated Hep191 cells in the absence of PNA under-
went apoptosis. Apoptotic cells showing DNA strand breaks
were clearly demonstrated by in situ labeling. In contrast,
the cells expressing HCV core protein exhibited little de-
tectable fluorescence.
We further examined whether the induction of HCV core
Fig. 4. Up-regulation of ICAD expression by the core protein. (A) ICAD and GAPDH expressed in Hep191 and HepRXR cells in the absence () or the
presence () of PNA were analyzed by Western blotting. (B) 293T cells were cotransfected with the ICAD promoter/luciferase construct (either pIPT-2, -3,
or -4) and the internal control pRL-TK in the presence of core-expressing pCAGC191 or control empty vector. Relative luciferase activity (RLU) was
determined at 24 h posttransfection. Results are expressed as a mean  S.D. of triplicate experiments.
28 R. Sacco et al. / Virology 317 (2003) 24–35
protein would inhibit the anti-Fas-stimulated caspase-3 ac-
tivity. Treatment of the core-induced Hep191 cells with
anti-Fas resulted in a decrease in the caspase-3 (or DEV-
Dase) activity in these cell lysates (Fig. 7A). Addition of
PNA may not affect the enzyme activity per se, because no
caspase-3 activity change was observed in HepRXR cells in
the presence of 10 M PNA. However, it is known that the
treatment with anti-Fas antibody triggers the cleavage of the
inactive proform of caspase-3 by an upstream caspase to
generate its active subunits (Dubrez et al., 1996). Thus, we
analyzed the level of 32-kDa procaspase-3, which decreases
upon enzyme activation, by Western blotting (Fig. 7B). As
expected, Hep191 cells without PNA treatment demon-
strated a decrease in the amount of the procaspase-3 in
response to anti-Fas antibody. By contrast, the level of
procaspase-3 in the cells treated with 10 M PNA was
comparable to that under no apoptotic stimuli. We observed
similar results in the other Hep191 clone, 37 (Fig. 7C),
confirming that activation of caspase-3 following treatment
with anti-Fas antibody was inhibited by induced expression
of the core protein. Since caspase-3 locates almost at the end
of the apoptotic cascade, its inhibition strongly indicates
Fig. 5. Quantitation of apoptotic DNA fragmentation. (A) Hep191 and HepRXR cells, which cultured in the presence or absence of 10 M PNA for 36 h,
were treated with anti-Fas antibody and CHX for a further 14 h. Apoptotic DNA fragmentation was measured using a sandwich enzyme-linked
immunosorbant assay system for cell death detection. Relative values are shown as means  S.D. of independent three experiments. (B) Hep191 cells were
grown in the presence of 10 M PNA with repeated replacing the medium for 15 or 30 days, followed by treating with either anti-Fas/CHX for 14 h or TNF-
for 48 h.
Fig. 6. Photomicrographs of Hep191 cells with induced expression of the core protein. Cells were cultured in the absence (B) or presence (C) of 10 M PNA
for 36 h, followed by treating with anti-Fas antibody and CHX for a further 14 h. PNA-treated cells without inducing apoptosis by anti-Fas/CHX were also
prepared (A). Apoptotic cells were visualized by TUNEL fluorescence analysis.
29R. Sacco et al. / Virology 317 (2003) 24–35
that induced expression of the HCV core protein at moder-
ate levels inhibits Fas-mediated DNA fragmentation in hu-
man liver cells.
Discussion
Deregulation of apoptosis or programmed cell death is
involved in a wide range of pathological processes, includ-
ing autoimmune hepatitis, fulminant hepatitis, and HCC.
Although there is increasing evidence that the HCV core
protein interacts with regulatory pathways controlling apo-
ptosis, the role of this protein remains controversial because
of the conflicting results in the literature, that is, its opposite
effects in either inhibition or potentiation of apoptosis. It is
likely that the expression level of the core protein, avail-
ability of apoptotic versus survival factors, and experimen-
tal setting might affect the fate of cells exposed to diverse
stimuli.
In the current study, we have introduced the ecdysone-
inducible expression system to establish a human hepato-
blastoma HepG2-based stable cell line, Hep191, allowing
tightly regulated expression of HCV core protein. In this
system, no background expression is observed in the ab-
sence of the inducer. It is also possible to precisely control
the expression levels in response to varying inducer con-
centrations. These are the advantages of using the ecdysone-
based system over other inducible systems, such as the
tetracycline-based system. Indeed, the ecdysone-inducible
system was developed to address a main flaw of the tetra-
cycline-inducible system, a relatively high background of
expression in the uninduced state (No et al., 1996). In
contrast to tetracycline, the lipophilic nature of the ecdys-
teroids such as PNA allows their efficient penetrance into
cells and appropriate pharmacokinetics that prevent storage
and expedite clearance, leading to a delicate temporal con-
trol of gene expression. Further, we observed no pleiotropic
effects of the inducing agent. Neither cytotoxicity nor in-
fluence on cell proliferation was observed in PNA-treated
cells (Fig. 2). The lack of baseline cross-talk between the
inducible system and endogenous cellular pathway is essen-
tial to study HCV–liver cell interaction. It is also notewor-
thy that the expression levels of HCV core protein in
Hep191 cells can be controlled to the level comparable to
those in the livers of hepatitis C patients and the HCV
core-transgenic mice developing hepatic steatosis and HCC
(Koike et al., 2002; Tsutsumi et al., 2003). In this regard,
most of the previous studies on possible roles of HCV core
protein in viral pathogenesis depended on overexpression
systems of either constitutively expressing cell lines or
transiently transfected cells. Thus, Hep191 cells based on
the ecdyson system may be useful as a model of HCV
core–host cell interaction closer to the virus infection set-
ting than previous expression systems. Liver cell specific
interaction included in this system would be important.
We applied this Hep191 cell line to analyze the gene
Fig. 7. Effect of the core protein on enzymatic activity and processing of caspase-3 (A) Hep191 (clone 3) and HepRXR cells grown in the presence of 0–10
M PNA for 40 h were treated with anti-Fas/CHX, followed by measuring caspase-3 activity in cell lysates as described under Materials and methods. Results
show the mean values of triplicate experiments. (B) Lysates from Hep191 cells (clone 3) cultured in the presence of 0–10 M PNA with or without anti-Fas
treatment were analyzed by Western blotting to detect procaspase-3 and GAPDH. (C) Same as in (B), but with the other Hep191 clone, 37.
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expression profiling by using cDNA microarray technique.
Clone-to-clone variability of cells can be controlled in this
inducible system. Taking this advantage, we investigated
the response of the same cells to two different stimuli. We
identified 20 genes (0.9% of 2304 transcripts examined)
which showed twofold or more difference between with and
without the core induction. Among them were several genes
related to transcriptional regulation, signaling, RNA/protein
metabolism, and apoptosis. We subsequently performed
semiquantitative RT-PCR of four apoptosis-related genes
and confirmed that ICAD and DAD1 were up-regulated, and
TNFR1 and cytochrome c oxidase subunit VIII were down-
regulated in the core-expressing cells.
With regard to ICAD, its promoter activity was up-
regulated by the core protein expression and steady-state
level of ICAD protein was subsequently increased. ICAD,
otherwise known as DFF45 (DNA fragmentation factor
45-kDa subunit), is a caspase-3 substrate which is cleaved
before apoptotic DNA fragmentation proceeds. Moreover,
ICAD is a specific inhibitor of CAD, also called DFF40
(DNA fragmentation factor 40-kDa subunit), and is a mo-
lecular chaperone which is involved in proper folding of the
endonuclease (reviewed by Nagata, 2000). It has been re-
ported that overexpression of ICAD inhibits staurosporine-
or Fas-induced DNA fragmentation (Sakahira et al., 1998).
To our knowledge, the data presented here are the first to
demonstrate increased expression of ICAD mediated by a
viral protein through enhancing its promoter activity. In this
study, we observed that in the core-expressing Hep191 cells
expression of CAD did not change, as determined by West-
ern blotting as well as cDNA microarray (data not shown).
The maintenance of a 1:1 ratio of ICAD and CAD might be
important for the homeostasis of normal cells, because an
excess of ICAD will increase the threshold for downstream
apoptotic signaling. Thus, our findings suggest that up-
regulation of ICAD by HCV core protein may contribute to
metabolic perturbation such as inhibition of apoptosis in
HCV-infected hepatocytes.
The DAD1 gene, identified as a defender against apo-
ptotic death gene, was also up-regulated. The DAD1 gene
encodes a subunit of the oligosaccharyltransferase enzyme
complex that initiates N-linked glycosylation (Nakashima et
al., 1993). This protein plays a role in inhibition of apoptosis
in some cultured cells (Yoshimi et al., 2000). Studies with
mice carrying a null allele for DAD1 showed that this gene
is required for proper processing of N-linked glycoproteins
and for certain cell survival (Hong et al., 2000). It is also of
interest that DAD1 gene is highly expressed in HCC cells
compared to adjacent nontumorous liver tissues through
differential display analysis (Tanaka et al., 2001).
TNFR1 is one of death receptors and relays death signals
through a cytoplasmic sequence motif called the death do-
main. Upon TNF engagement, TNFR1 binds other death
domain-containing proteins and subsequently leads to acti-
vation of caspases, resulting in apoptosis (for review, see
Ashkenazi and Dixit, 1998). Down-regulation of TNFR1 in
our study is not consistent with the previous report showing
HCV core protein binds to the cytoplasmic domain of
TNFR1 and enhances TNF-induced apoptosis of certain
mouse and human cells. In these cells, the presence of core
protein did not alter the expression of TNFR1 (Zhu et al.,
1998, 2001). The difference in the conditions of either cell
culture or core expression may be attributed to this discrep-
ancy.
Cytochrome c oxidase is the terminal enzyme complex in
the mitochondrial respiratory chain, and cytochrome c oxi-
dase subunit VIII is one of the 13 subunits of the complex.
A progressive reduction in respiratory activity of cyto-
chrome c oxidase induces cytochrome c release in anti-Fas-
triggered apoptotic cells (Hajek et al., 2001). The release
from the mitochondrial intermembrane space into the cy-
tosol involves the activation of the apoptotic protease cas-
cade together with Apaf-1 and procaspase-9 (Li et al.,
1997). Interestingly, cytochrome c release from mitochon-
dria is inhibited in the liver of HCV protein-expressing
transgenic mice, in which Fas-mediated apoptotic cell death
was suppressed (Machida et al., 2001). Nevertheless, the
underlying mechanism of cytochrome c release is not well
known yet. Further studies on down-regulation of cyto-
chrome c oxidase subunit VIII in relation to respiratory
activity of cytochrome c oxidase and cytochrome c release
in our experimental setting are necessary.
We characterized the effect of HCV core protein on the
cytokine-mediated apoptotic pathway in Hep191 cells. The
cytokines Fas ligand and TNF- are the critical components
necessary for triggering receptor-mediated cell death in
vivo. We show here that the core protein confers resistance
against apoptotic DNA fragmentation induced by either
anti-Fas antibody or TNF- (Figs. 5 and 6). Our data con-
firmed that the pleiotropic effects of PNA do not cause this
phenomenon, since we found no influence on the Fas-me-
diated apoptosis in control HepRXR cells even with a high
concentration of PNA (30 M). To avoid clonal diversity
during the selection of permanent transfectants, we also
analyzed HepG2 cells transiently transfected with both
core-expressing pIND191 and pVgRXR. We observed sim-
ilar results of antiapoptotic response (data not shown).
Caspase-3 is recognized as an important effector mole-
cule in the apoptotic pathway, and its activity arises follow-
ing the cleavage of inactive proenzyme (procaspase-3) after
Fas or TNFR is stimulated. We show here that expression of
core protein inhibits caspase-3 activity induced by anti-Fas.
It was shown by quantifying the enzyme activity in cell
extracts and monitoring the level of inactive 32-kDa pro-
caspase-3. Previously some reports indicated that HCV pro-
teins, particularly core protein, are involved in augmenta-
tion of caspase activation induced by anti-Fas or TNF-
(Ruggieri et al., 1997; Hahn et al., 2000), whereas others
indicated its suppression (Marusawa et al., 1999; Otsuka et
al., 2002; Machida et al., 2001). Since different experimen-
tal systems were used in these studies, the observed incon-
sistency may be due to the possible involvement of cellular
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factor(s) in certain cells. Alternatively, the expression level
of the core protein may be different. A previous report from
our laboratory demonstrated that the core protein sensitizes
Fas-mediated apoptosis possibly accompanied by up-regu-
lation of caspase-3 (Ruggieri et al., 1997). We used Hep39
cells in that study. Hep39 cells are also originated from
HepG2 cells and constitutively expresses the HCV core
protein. Subsequently, we compared the steady-state level
of the core protein in Hep39 and in Hep191 cells established
in this study. The level in Hep39 cells is 100- to 500-fold
higher than in Hep191 cells treated with 10 M PNA
determined by FEIA (data not shown).
It is generally accepted that caspase-3 is the primary
inactivator of ICAD and is mainly involved in proteolytic
pathways that induce apoptotic internucleosomal DNA frag-
mentation (Wolf et al., 1999). The results in the present
study suggest that up-regulation of ICAD and inhibition of
caspase-3 activity induced by the core protein collabora-
tively play roles in blocking DNase activity of CAD and
consequently in inhibiting DNA fragmentation in human
liver cells, which express the viral protein at moderate levels
comparable to that found in patients with chronic liver
diseases.
In conclusion, we established a tightly regulated induc-
ible expression system of HCV core protein in human liver
cells, where expression of the viral protein is promptly
induced to physiological levels. Transcriptional profiling,
coupled with studies to confirm gene expression, in this
system allowed us to identify several interesting genes that
may be involved in cell growth or apoptosis. Evidence that
the core protein modulates ICAD expression and the path-
way of caspase-3 activation should contribute to the under-
standing of the molecular mechanisms of HCV persistence
and chronic liver diseases. Functional studies in the future to
evaluate the significance of potential core-regulated genes
implicating not only in apoptosis but in other cellular pro-
cesses may also provide new directions for the detailed
investigation of HCV pathogenesis.
Materials and methods
Construction of inducible expression vector for HCV core
protein
HCV cDNA (nt 342 to 914), coding for the entire core
protein (aa 1 to 191), was excised from the BglII site of the
pCAGC191 (Suzuki et al., 2001) and inserted, using stan-
dard cloning procedures (Sambrook et al., 1989), into the
BamHI site of the inducible expression vector pIND/Hygro
(Invitrogen, Carlsbad, CA) to yield plasmid pIND191. This
vector contains five ecdysone/glucocorticoid response ele-
ments which allow binding of the modified VgEcR for
activation of gene transcription and inducible expression of
HCV core protein gene under control of a Drosophila min-
imal heat shock promoter. Hygromycin resistance gene in
the vector allows selection of stable transfectant in mam-
malian cells.
Establishment of an inducible cell line
Stock cultures of human hepatoblastoma HepG2 cells
were maintained in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% FBS, 100 units/ml of
penicillin, and 100 mg/ml of streptomycin and kept at 37°C
in a 5% CO2 incubator. To generate a stable cell line
allowing tightly regulated expression of HCV core protein,
HepG2 cells were cotransfected with both plasmid
pIND191 and pVgRXR (Invitrogen). The latter vector that
contains the gene conferring Zeocin resistance also encodes
modified ecdysone receptor (VgEcR) and the retinoid X
receptor. This vector thus provides an ecdysone functional
heterodimeric receptor for activation of gene expression
upon binding to an ecdysone analog, such as PNA (Invitro-
gen) (No et al., 1996).
Monolayers of HepG2 cells were transfected with the
plasmids in the presence of Trans-lT LT1 (Mirus Corp. WI)
according to the manufacturer’s instructions. After transfec-
tion, transformants were selected in DMEM containing 500
g/ml of Hygromycin (Roche Diagnostics, Basel, Switzer-
land) and 400 g/ml of Zeocin (Invitrogen) for 3 to 5
weeks. Individual colonies were isolated and amplified,
followed by screening inducible expression of HCV core
protein. After 24 h of incubating the amplified clones in the
medium with PNA at 10 M, expression of the core protein
was determined by a sensitive FEIA (Kashiwakuma et al.,
1996) (see below). Stable cell lines, which allow tightly
regulated expression of the core protein, were designated as
Hep191.
To obtain a control cell line not expressing HCV core
protein, HepG2 cells were transfected with the plasmid
pVgRXR. After transfection, transformants were selected in
DMEM medium containing 400 g/ml of Zeocin. The iso-
lated resistant colonies were designated as HepRXR.
Quantitation of HCV core protein
Hep 191 cells were induced to express HCV core protein
using PNA at various concentrations ranging from 0.3 to 30
M for indicated periods. Expressed core protein was quan-
titated by FEIA method as reported previously (Kashiwa-
kuma et al., 1996). Briefly, cells were homogenized in a
solution containing 0.3% Triton X-100, 1.5% (3-cholami-
dopropyl dimethylammonio) propanesulfonic acid, and
15% sodium dodecyl sulfate (SDS). After incubating at
56°C for 30 min, the samples were centrifuged at 1000 rpm
for 5 min, and the supernatants were subjected to FEIA.
Total protein concentration of the lysates was determined
using the Pierce Micro BCA protein Assay Reagent Kit
according to the manufacturer’s instructions (Pierce, Rock-
ford, IL).
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Western blot analysis
Cells were washed with phosphate-buffered saline (PBS)
and lysed in SDS sample buffer. Cell lysates were separated
by 15 or 12.5% SDS–polyacrylamide gel electrophoresis
(SDS–PAGE) and electrotransferred to polyvinylidene di-
fluoride membrane (Immobilion; Millipore Ltd., Bredford,
MA). After blocking in nonfat milk solution (Block Ace,
Yukijirushi Co., Sapporo, Japan), the membranes were
probed with the monoclonal antibody against HCV core
protein (B2, ANOGEN, Missisauga, Canada), as a primary
antibody diluted 1:200 and incubated for 1 h at 37°C. After
being washed, the membranes were incubated with horse-
radish peroxidase conjugated sheep anti-mouse or anti-rab-
bit immunoglobulins as secondary antibodies. Antigen-
antibody complexes were visualized by enhanced chemilu-
minescence detection system (ECL; Amersham Bio-
sciences, Piscataway, NJ) according to the manufacturer’s
protocol.
Immunofluorescence microscopy
For indirect immunofluorescence staining of HCV core
protein, Hep191 cells were grown in a tissue chamber slide
in the presence of 30 M PNA for 48 h and fixed with 4%
paraformaldehyde, followed by permeabilizing with 0.2%
Triton X-100. After blocking in nonfat milk solution (Block
Ace), cells were incubated for 1 h with the anticore mono-
clonal antibody. Following washing, cells were incubated
for 1 h with Biotin-conjugated antibody to mouse immuno-
globulin (Sigma-Aldrich, St. Louis, MO). To increase sen-
sitivity and specificity of the antigen detection, ExtrAvidin
conjugated with FITC (Sigma-Aldrich) was then added and
incubated for 1 h, followed by examining with a fluorescent
microscopy.
Cell growth property
To test cell growth of Hep191, 6  104 cells per well
were seeded into six-well tissue culture plates. Cells were
cultured in DMEM with FBS 10 or 1% and the medium
with and without 10 M PNA was changed daily. Cells
from triplicate wells were harvested and viable cells were
counted every other day for 10 days by trypan blue dye
exclusion.
RT-PCR
Total RNAs were extracted from Hep191 and HepRXR
cells using SV Total RNA Isolation System (Promega,
Madison, WI) according to the manufacturers’ protocols.
Three micrograms of total RNAs was reverse transcribed by
Superscript II (Invitrogen) using oligo(dT) primer. Ampli-
fication procedure using specific PCR primers was as fol-
lows: after 3 min at 96°C, the reaction of 96°C for 30 s,
55°C for 30 s, 72°C for 1 min was repeated for 20–30
cycles, and finally 10 min at 72°C for one cycle. A mini-
mum amount of PCR cycle was carried out to stay within
the linear amplification process for each gene. PCR products
were electrophoresed on 2.0% agarose/ethidium bromide
gels.
Microarray analysis
Preparation procedure of cDNA microarray was de-
scribed previously (Yoshikawa et al., 2000; Otsuka et al.,
2001). Total RNAs from Hep191 in the presence or absence
of PNA at 10 M for 36 h were isolated with ISOGEN
Reagent (Nippon Gene, Tokyo, Japan). Poly(A) RNAs
were obtained with Oligotex-dT 30 mRNA purification kit
(TaKaRa Bio. Inc., Kyoto, Japan), according to the manu-
facturer’s instructions. Fluorescent nucleotide Cy3-dUTP or
Cy5-dUTP was incorporated during reverse transcription of
the poly(A) RNA. The probes were purified and concen-
trated by passing through Centricon-30 microconcetrators
(Millipore). The different fluorescence-labeled probes were
mixed and applied onto a microarray slide. Hybridization
was carried out at 65°C overnight under a humidified con-
dition. The array was washed, centrifuged, and then scanned
with a fluorescence laser confocal slide scanner (Scan Array
4000, GSI Lumonics, Tokyo, Japan). Images were analyzed
and fluorescence intensities were measured by Quant Array
(GSI Lumonics). Genes showing changes in expression by
twofold or more in the average of two experiments, where
labeling with the fluorescent dyes were switched during the
synthesis, were considered as differentially expressed
genes.
Anti-Fas and TNF--induced apoptotic response
Hep191 and HepRXR were cultured in the presence of
10 M PNA for 36 h, followed by treating with anti-Fas
antibody (CH-11; MBL, Nagoya, Japan) or recombinant
human TNF- (Sigma-Aldrich). Anti-Fas antibody and
TNF- were used at final concentrations of 100 and 10
ng/ml, respectively. The minimum concentration of cyclo-
heximide (CHX) required for anti-Fas-induced apoptosis
was previously determined as a final concentration of 500
ng/ml (Marusawa et al., 1999). After 14 or 48 h from the
start of anti-Fas- or TNF- treatment, respectively, apopto-
tic cell death was measured by Cell Death Detection
ELISAPLUS (Roche Diagnostics) according to the manu-
facturer’s instructions. This assay is based on the specific
determination of mononucleosomes and oligonucleosomes
in the cytoplasmic fraction of apoptosis-induced cells. Anti-
Fas-induced apoptotic response in Hep191 was also evalu-
ated using the TUNEL procedure using In Situ Cell Death
Detection Kit, Fluorescein (Roche Diagnostics). Cells incu-
bated in chamber slides were fixed with 4% paraformalde-
hyde in PBS, followed by permeabilization with 0.1% Tri-
ton X-100 in 0.1% sodium citrate. DNA strand breaks
generated during apoptosis were fluorescein-labeled and
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detected by fluorescence microscopy. Caspase-3 activity
in the anti-Fas-treated Hep191 was evaluated by the
CaspACETM Assay System (Promega), according to the
manufacturer’s instructions. Cytosolic proteins were incu-
bated with the colorimetric substrate Ac-DEVD-pNA in the
presence or absence of the caspase inhibitor Z-VAD-FMK.
Released pNA, p-nitroaniline, from the substrate upon
cleavage by caspase-3 activity was monitored by a photom-
eter at 405 nm. Total protein concentration of the cell
lysates was determined using the Pierce Micro BCA protein
Assay Reagent Kit (Pierce).
Luciferase assay
Human embryonic kidney 293T cells in 24-mm-diameter
dishes were transfected with 0.5 g of HCV-core express-
ing plasmid pCAGC191 or control pCAGGS, 0.2 g of a
reporter plasmid containing ICAD promoter either pIPT-2,
-3, or -4 (Kawane et al., 1999), and 0.01 g of pRL-TK
(Promega). After 24 h, cells were harvested, and luciferase
activities were determined by the Dual-Luciferase Reporter
Assay System (Promega) as described previously (Aoki et
al., 1998). The measured firefly luciferase activities were
normalized for transfection efficiency using the values of
Renilla luciferase activity determined from the same cell
extracts.
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